Short-Term Treatment with Bisphenol-A Leads to Metabolic Abnormalities in Adult Male Mice

Abstract

Bisphenol-A (BPA) is one of the most widespread endocrine disrupting chemicals (EDC) used as the base compound in the manufacture of polycarbonate plastics. Although evidence points to consider exposure to BPA as a risk factor for insulin resistance, its actions on whole body metabolism and on insulin-sensitive tissues are still unclear. The aim of the present work was to study the effects of low doses of BPA in insulin-sensitive peripheral tissues and whole body metabolism in adult mice. Adult mice were treated with subcutaneous injection of 100 µg/kg BPA or vehicle for 8 days. Whole body energy homeostasis was assessed with in vivo indirect calorimetry. Insulin signaling assays were conducted by western blot analysis. Mice treated with BPA were insulin resistant and had increased glucose-stimulated insulin release. BPA-treated mice had decreased food intake, lower body temperature and locomotor activity compared to control. In skeletal muscle, insulin-stimulated tyrosine phosphorylation of the insulin receptor β subunit was impaired in BPA-treated mice. This impairment was associated with a reduced insulin-stimulated Akt phosphorylation in the Thr(308) residue. Both skeletal muscle and liver displayed an upregulation of IRS-1 protein by BPA. The mitogen-activated protein kinase (MAPK) signaling pathway was also impaired in the skeletal muscle from BPA-treated mice. In the liver, BPA effects were of lesser intensity with decreased insulin-stimulated tyrosine phosphorylation of the insulin receptor β subunit.In conclusion, short-term treatment with low doses of BPA slows down whole body energy metabolism and disrupts insulin signaling in peripheral tissues. Thus, our findings support the notion that BPA can be considered a risk factor for the development of type 2 diabetes.

References 51

1. 1.

   Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867.

   Not in our library10.1038/nature05485

2. 2.

   Beard JC, Ward WK, Halter JB, Wallum BJ, Porte D. Relationship of islet function to insulin action in human obesity. J Clin Endocrinol Metab. 1987;65:59-64.

   Not in our library10.1210/jcem-65-1-59

3. 3.

   Alonso-Magdalena P, Quesada I, Nadal A. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol. 2011;7:346-353.

   Not in our library10.1038/nrendo.2011.56

4. 4.

   Hectors TL, Vanparys C, van der Ven K, Martens GA, Jorens PG, et al. Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia. 2011;54:1273-1290.

   Not in our library10.1007/s00125-011-2109-5

5. 5.

   Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol. 2011;73:135-162.

   Not in our library10.1146/annurev-physiol-012110-142200

6. 6.

   Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24:139-177.

   Not in our library10.1016/j.reprotox.2007.07.010

7. 7.

   Shankar A, Teppala S. Relationship between urinary bisphenol A levels and diabetes mellitus. J Clin Endocrinol Metab. 2011;96:3822-3826.

   Not in our library10.1210/jc.2011-1682

8. 8.

   Wang T, Li M, Chen B, Xu M, Xu Y, et al. Urinary Bisphenol A (BPA) Concentration Associates with Obesity and Insulin Resistance. J Clin Endocrinol Metab. 2012;97:E223-227.

   Not in our library10.1210/jc.2011-1989

9. 9.

   Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB. The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol. 2009;304:63-68.

   Not in our library10.1016/j.mce.2009.02.016

10. 10.

    Talsness CE, Andrade AJ, Kuriyama SN, Taylor JA, vom Saal FS. Components of plastic: experimental studies in animals and relevance for human health. Philos Trans R Soc Lond B Biol Sci. 2009;364:2079-2096.

    Not in our library10.1098/rstb.2008.0281

11. 11.
    Similarity of Bisphenol A Pharmacokinetics in Rhesus Monkeys and Mice: Relevance for Human Exposure · 2010

    No notice
12. 12.
    Bisphenol A Data in NHANES Suggest Longer than Expected Half-Life, Substantial Nonfood Exposure, or Both · 2009

    No notice
13. 13.

    Zalko D, Jacques C, Duplan H, Bruel S, Perdu E. Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere. 2011;82:424-430.

    Not in our library10.1016/j.chemosphere.2010.09.058

14. 14.
    Exposure of the U.S. Population to Bisphenol A and 4- tertiary -Octylphenol: 2003–2004 · 2007

    No notice
15. 15.
    The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance · 2005

    No notice
16. 16.
    Bisphenol A Exposure during Pregnancy Disrupts Glucose Homeostasis in Mothers and Adult Male Offspring · 2010

    No notice
17. 17.
    Persistent Organic Pollutant Exposure Leads to Insulin Resistance Syndrome · 2009

    No notice
18. 18.

    Wei J, Lin Y, Li Y, Ying C, Chen J, et al. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology. 2011;152:3049-3061.

    Not in our library10.1210/en.2011-0045

19. 19.
    Pancreatic Insulin Content Regulation by the Estrogen Receptor ERα · 2008

    No notice
20. 20.

    Oliveira AG, Carvalho BM, Tobar N, Ropelle ER, Pauli JR, et al. Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats. Diabetes. 2011;60:784-796.

    Not in our library10.2337/db09-1907

21. 21.

    Adachi T, Yasuda K, Mori C, Yoshinaga M, Aoki N, et al. Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors. Food Chem Toxicol. 2005;43:713-719.

    Not in our library10.1016/j.fct.2005.01.009

22. 22.
    Rapid Insulinotropic Action of Low Doses of Bisphenol-A on Mouse and Human Islets of Langerhans: Role of Estrogen Receptor β · 2012

    No notice
23. 23.

    Wong WP, Tiano JP, Liu S, Hewitt SC, Le May C, et al. Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc Natl Acad Sci U S A. 2010;107:13057-13062.

    Not in our library10.1073/pnas.0914501107

24. 24.

    Barros RP, Machado UF, Gustafsson JA. Estrogen receptors: new players in diabetes mellitus. Trends Mol Med. 2006;12:425-431.

    Not in our library10.1016/j.molmed.2006.07.004

25. 25.

    Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids. 2008;73:874-879.

    Not in our library10.1016/j.steroids.2007.12.018

26. 26.

    Faulds MH, Zhao C, Dahlman-Wright K, Gustafsson JA. The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol. 2011;212:3-12.

    Not in our library10.1530/joe-11-0044

27. 27.

    Park CJ, Zhao Z, Glidewell-Kenney C, Lazic M, Chambon P, et al. Genetic rescue of nonclassical ERalpha signaling normalizes energy balance in obese ERalpha-null mutant mice. J Clin Invest. 2011;121:604-612.

    Not in our library10.1172/jci41702

28. 28.

    Soriano S, Ropero AB, Alonso-Magdalena P, Ripoll C, Quesada I, et al. Rapid regulation of K(ATP) channel activity by 17β-estradiol in pancreatic β-cells involves the estrogen receptor β and the atrial natriuretic peptide receptor. Mol Endocrinol. 2009;23:1973-1982.

    Not in our library10.1210/me.2009-0287

29. 29.

    Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf). 2011;203:259-269.

    Not in our library10.1111/j.1748-1716.2010.02237.x

30. 30.

    Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol. 2007;24:178-198.

    Not in our library10.1016/j.reprotox.2007.05.010

31. 31.

    Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes. 2006;55:978-987.

    Not in our library10.2337/diabetes.55.04.06.db05-1339

32. 32.

    Gao Q, Mezei G, Nie Y, Rao Y, Choi CS, et al. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med. 2007;13:89-94.

    Not in our library10.1038/nm1525

33. 33.

    Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, et al. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci U S A. 2007;104:2501-2506.

    Not in our library10.1073/pnas.0610787104

34. 34.

    Cederroth CR, Vinciguerra M, Kuhne F, Madani R, Doerge DR, et al. A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environ Health Perspect. 2007;115:1467-1473.

    Not in our library10.1289/ehp.10413

35. 35.
    Bisphenol A at Environmentally Relevant Doses Inhibits Adiponectin Release from Human Adipose Tissue Explants and Adipocytes · 2008

    No notice
36. 36.

    Leng Y, Karlsson HK, Zierath JR. Insulin signaling defects in type 2 diabetes. Rev Endocr Metab Disord. 2004;5:111-117.

    Not in our library10.1023/b:remd.0000021432.84588.f6

37. 37.

    Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, et al. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes. 2005;54:1692-1697.

    Not in our library10.2337/diabetes.54.6.1692

38. 38.

    Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest. 2000;105:311-320.

    Not in our library10.1172/jci7535

39. 39.

    Lazar DF, Wiese RJ, Brady MJ, Mastick CC, Waters SB, et al. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem. 1995;270:20801-20807.

    Not in our library10.1074/jbc.270.35.20801

40. 40.

    Glass DJ. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol. 2010;346:267-278.

    Not in our library10.1007/82_2010_78

41. 41.

    Hamdi MM, Mutungi G. Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism. J Physiol. 2011;589:3623-3640.

    Not in our library10.1113/jphysiol.2011.207175

42. 42.

    Maroni P, Citterio L, Piccoletti R, Bendinelli P. Sam68 and ERKs regulate leptin-induced expression of OB-Rb mRNA in C2C12 myotubes. Mol Cell Endocrinol. 2009;309:26-31.

    Not in our library10.1016/j.mce.2009.05.021

43. 43.

    DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes. 1997;5:177-269.

    Not in our library

44. 44.

    McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 1992;258:766-770.

    Not in our library10.1126/science.1439783

45. 45.

    Devedjian JC, George M, Casellas A, Pujol A, Visa J, et al. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest. 2000;105:731-740.

    Not in our library10.1172/jci5656

46. 46.

    Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, et al. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia. 1994;37:1025-1035.

    Not in our library10.1007/bf00400466

47. 47.

    Phrakonkham P, Viengchareun S, Belloir C, Lombes M, Artur Y, et al. Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J Steroid Biochem Mol Biol. 2008;110:95-103.

    Not in our library10.1016/j.jsbmb.2008.02.006

48. 48.

    Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, et al. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol. 2004;141:209-214.

    Not in our library10.1038/sj.bjp.0705520

49. 49.

    Wada K, Sakamoto H, Nishikawa K, Sakuma S, Nakajima A, et al. Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci. 2007;105:133-137.

    Not in our library10.1254/jphs.fm0070034

50. 50.

    Prins GS, Ye SH, Birch L, Ho SM, Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod Toxicol. 2011;31:1-9.

    Not in our library10.1016/j.reprotox.2010.09.009

51. 51.

    Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. Jama. 2008;300:1303-1310.

    Not in our library10.1001/jama.300.11.1303

Cited by papers we hold 2

• Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease · 2019
  No notice
• Exposure to Bisphenol-A during Pregnancy Partially Mimics the Effects of a High-Fat Diet Altering Glucose Homeostasis and Gene Expression in Adult Male Mice · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.